Home › Funds › SHAPIRO CAPITAL MANAGEMENT LLC › ELAN

SHAPIRO CAPITAL MANAGEMENT LLC position in ELAN

ELANCO ANIMAL HEALTH INC · Health Care

SHAPIRO CAPITAL MANAGEMENT LLC reported holding 2,367,270 shares of ELAN (ELANCO ANIMAL HEALTH INC) in its Q3 2026 13F filing — a position valued at US$53.0M, representing 3.62% of its reported portfolio and ranking #6 among its reported holdings. SHAPIRO CAPITAL MANAGEMENT LLC has disclosed ELAN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.37M sh
Reported value held$53.00M
Portfolio Weight3.62%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SHAPIRO CAPITAL MANAGEMENT LLC's ELAN position evolved

SHAPIRO CAPITAL MANAGEMENT LLC first disclosed a stake in ELAN in Q3 2023 at 15,795,714 shares (US$177.5M). The position peaked in Q4 2023 at 14,559,024 shares, worth US$216.9M. Across 13 filings, SHAPIRO CAPITAL MANAGEMENT LLC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,367,270 shares valued at US$53.0M — a reduction of -284,140 shares quarter over quarter.. Notable position changes include a 25% trim in Q1 2024 (shares fell 11% over the following quarter), a 31% trim in Q3 2025 (shares rose 12% over the following quarter), a 47% trim in Q4 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 15.80M $177.54M New
Q4 2023 14.56M $216.93M Reduce
Q1 2024 10.89M $177.34M Reduce
Q2 2024 9.55M $137.86M Reduce
Q3 2024 11.49M $168.84M Add
Q4 2024 12.36M $149.64M Add
Q1 2025 12.33M $129.49M Hold
Q2 2025 9.29M $132.67M Reduce
Q3 2025 6.40M $128.83M Reduce
Q4 2025 3.37M $76.17M Reduce
Q1 2026 2.97M $71.00M Reduce
Q2 2026 2.65M $65.25M Reduce
Q3 2026 2.37M $53.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELAN and 13F data

ELAN (ELANCO ANIMAL HEALTH INC) is a Health Care company. 34 other funds we track also report a position in ELAN — the largest reported positions include Dodge & Cox (US$1.66B), DODGE & COX (US$1.66B), PRIMECAP MANAGEMENT CO/CA/ (US$1.02B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELAN

All ELAN fund holders →

FAQ

How long has SHAPIRO CAPITAL MANAGEMENT LLC held ELAN?

SHAPIRO CAPITAL MANAGEMENT LLC has disclosed ELAN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SHAPIRO CAPITAL MANAGEMENT LLC's current position in ELAN?

As of Q3 2026, SHAPIRO CAPITAL MANAGEMENT LLC holds 2.37M shares of ELAN (ELANCO ANIMAL HEALTH INC), valued at $53.00M, representing 3.62% of its reported portfolio and ranking #6.

Has SHAPIRO CAPITAL MANAGEMENT LLC been buying or selling ELAN?

In the latest 13F filing (Q3 2026), SHAPIRO CAPITAL MANAGEMENT LLC reduced its position in ELAN. The position peaked in Q4 2023 at 14.56M shares.

Which other funds hold ELAN?

Other major institutional holders of ELAN include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.